On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Biomimx SRL's own share of each project, not the project's full budget.
- Horizon Europe€2.3M · 8 projects
- Horizon 2020€312k · 2 projects
Projects
10 EU-funded projects, newest first. Biomimx SRL led 2 of them as coordinator. Each links to the official record.
- GlycoAxisPartner
Training the next generation of scientists on cell surface Glycans from Gram-negative gut microbiota as molecular keys to decOde the gut-immune-brain Axis
Horizon Europe · 2027–2030 · Project on CORDIS ↗
€282ktheir share - BATTITOPartner
uBeAt-powered closed-loop sTandardisaTion of beatIng heart-on-chip for reliable cardioTOxicity screening
Horizon Europe · 2026–2028 · Project on CORDIS ↗
€75ktheir share - AI-RITMIAPartner
AI-assisted peRsonalized heart-on-chIp as advanced diagnostic Tool for clinical significance assessMent of Inherited cArdiomyopathies
Horizon Europe · 2026–2029 · Project on CORDIS ↗
€580ktheir share - MATRIxAssociated partner
Understanding Nanoparticle Transport Mechanisms in the Melanoma Microenvironment via a Tumor-on-a-Chip Approach
Horizon Europe · 2025–2028 · Project on CORDIS ↗
- PHOENIXPartner
PHOENIX: Precision Human Organs-on-chip for Enhanced Neuro-muscular and Cardiac Studies
Horizon Europe · 2025–2028 · Project on CORDIS ↗
€787ktheir share - IMPLANTEUPartner
Innovative approaches to implantation research in health and disease
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€259ktheir share - MIRACLEPartner
Multilevel inflammatory regulation in cardiometabolic disease
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€259ktheir share - uBeatCoordinator
Mimic human complexity in a Beat to revolutionize the drug development
Horizon Europe · 2022–2022 · Project on CORDIS ↗
€75ktheir share - uHeartCoordinator
A beating Heart-on-Chip for pre-clinical early detection of drugs cardiac safety
Horizon 2020 · 2019–2020 · Project on CORDIS ↗
€50ktheir share - SINERGIAPartner
advanced technologieS for drug dIscovery and precisioN mEdicine: in vitRo modellinG human physiology and diseAse
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€262ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Politecnico di MilanoItaly · 7 shared projects
- Katholieke Universiteit LeuvenBelgium · 2 shared projects
- Universiteit MaastrichtNetherlands · 2 shared projects
- Universitaet BernSwitzerland · 2 shared projects
- Humanitas Mirasole SpAItaly · 2 shared projects
- Naturwissenschaftliches und Medizinisches Institut An der Universitaet TuebingenGermany · 2 shared projects
- Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 1 shared project
- Technische Universiteit DelftNetherlands · 1 shared project
- Consiglio Nazionale Delle RicercheItaly · 1 shared project
- Universiteit GentBelgium · 1 shared project
- Technische Universitaet MuenchenGermany · 1 shared project
- Ludwig-Maximilians-Universitaet MuenchenGermany · 1 shared project
- Helsingin YliopistoFinland · 1 shared project
- Universiteit van AmsterdamNetherlands · 1 shared project
- The University of ManchesterUnited Kingdom · 1 shared project
- University College Dublin, National University of Ireland, DublinIreland · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- carbohydrates
- cardiovascular diseases
- drug discovery
- drug safety
- embryology
- gene therapy
- immunology
- melanoma
- microbiology
- microelectronics
- nano-materials
- nanomedicine
- neurobiology
- obstetrics
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.
